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Background: Partial duplication 1q is a rare cytogenetic anomaly frequently associated to deletion of another
chromosome, making it difficult to define the precise contribution of the different specific chromosomal segments
to the clinical phenotype.
Case presentation: We report a clinical and cytogenomic study of a patient with multiple congenital anomalies,
heart defect, neuromotordevelopment delay, intellectual disability, who presents partial trisomy 1q32 and partial
monosomy 11q25 inherited from a paternal balanced translocation identified by chromosome microarray and
fluorescence in situ hybridization.
Conclusion: Compared to patients from the literature, the patient’s phenotype is more compatible to the 1q32
duplication’s clinical phenotype, although some clinical features may also be associated to the deleted segment on
chromosome 11. This is the smallest 11q terminal deletion ever reported and the first association between 1q32.3
duplication and 11q25 deletion in the literature.
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Clinical follow-upBackground
Partial duplication 1q is a rare cytogenetic anomaly
frequently associated to deletion of another chromosome,
making it difficult to define the precise contribution of the
different specific chromosomal segments to the clinical
phenotype. The duplicated material can result either from
an inherited rearrangement or due to an unbalanced de
novo translocation, duplication, or insertion [1]. The
terminal duplication 1q is associated to pre and postnatal
growth retardation, dysmorphisms, multiple congenital
malformations, including heart defects, and intellectual
disability [2]. Only 12 patients have been described in
literature with duplication of the distal long arm of* Correspondence: lesliekulik@usp.br
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unless otherwise stated.chromosome 1 without other concomitant chromosomal
imbalance [3-14]. Most cases of these 1q duplication
involve the 1q32qter region; and translocations involve mul-
tiple chromosomes, including 3p, 5p, 7p, 21q, and Xq [15].
The 11q terminal deletion was first described by
Jacobsen et al. [16] and has a recognized pattern of
malformation. Jacobsen syndrome (JBS, OMIM 147791) is
a contiguous gene disorder caused by 7 to 20 Mb 11qter
deletions. More than 100 cases have been described in
literature and the clinical findings include developmental
delay, short stature, congenital heart defects (CHD),
thrombocytopenia, genitourinary anomalies, pyloric
stenosis, and ophthalmologic anomalies.
Here we report on a patient with a duplication of
37 Mb of the distal long arm of chromosome1 from
1q32 to 1qter associated to a 2 Mb 11q25qter deletion
inherited from his father’s balanced translocation.
SNP-array and fluorescence in situ hybridization (FISH)
techniques were used to define the specific breakpoints.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with previous patients with distal 1q duplication and
distal 11q deletion.
Case presentation
The Research Ethics Committee of UNIFESP approved
this study, and consent was obtained from the patient’s
parents. The male patient is the first child of a young
non-consanguineous and healthy couple and has one
normal sister and one paternal half-sister. He was
born at term by vaginal delivery after a pregnancy
with hypertension and a bleeding episode, with a
birth weight of 1,980 g (10th centile), length 42 cm
(10th-25th centile), and occipital frontal circumference
(OFC) unavailable. He stayed 11 days in the nursery because
of low birth weight and dysmorphisms. Hematologic
abnormalities were not observed during the neonatal
period. At the age of three months, a computerized
cranial tomography showed hydrocephaly and at age
of six months, the echocardiography showed pulmonary
stenosis. At one year old, he had endocarditis, being
hospitalized for 18 days. He also had three episodes
of bronchopneumonia by the age of two years. At
one year and 10 months old, he presented height of
72 cm (<5th centile), weight of 7,200 g (<5th centile), OFC
of 47 cm (10th-25th centile). The clinical evaluation
revealed: microsomia, relative macrocephaly, brachycephaly,Figure 1 Patient at 1 year and 10 months (a) and 14 years of age (b) sh
showing paternal balanced translocation (c); Partial FISH metaphase wi
segment (d); BAC-FISH results showing the breakpoint delineation in 1q
result for duplication (blue bar) 1q32.(212,508,954-249,224,376) × 3 (g);downslanted palpebral fissures, long and marked eyelashes,
synophrys, large ears, hipoplastic ala nasi, prominent nose,
high nasal bridge, long and smooth philtrum, abnormal
tooth implantation, high palate, forehead abnormal
hair implantation, hirsutism, pectus carinatum, thoracic
asymmetry, vertical palmar creases one on the left hand
and two on the right, overlying position of toes, micropenis
and bilateral cryptorchidism (Figure 1a). He evolved with
moderate development and speech delay, and had a few
convulsion episodes at age of two years. A new cardiac
evaluation showed atrial septal defect, which was surgically
corrected at age of 5 years. The clinical evaluation at age of
ten years showed: height 119 cm (<5th centile), weight
25 kg (5th centile) and OFC 50.5 cm (50th centile). At
this time, the patient additionally presented muscular
hypotonia and presented with moderate intellectual
disability, aggressive and hyperactive behavior, limited
verbal language repertoire and dysarthria. At age of
14 years, he showed height 125 cm (<5th centile),
weight 26 kg (5th centile) and OFC 52.5 cm (50th centile)
(Figure 1b). At this time, the patient underwent an
assessment of intellectual and neuropsychological
skills and had a very limited verbal repertoire, but
showed communicative intention, good eye contact
and used some gestures to express his intentions. Other
behavioral characteristics included mild psychomotor
disabilities and lack of symbolic skills, indicating severeowing the facial dysmorphic features; Partial G-banding karyotype
th WCP1 probe showing the patient’s der(11) with the duplicated
32.3 and 11q25 regions in father’s metaphases (e and f); Array
and deletion (red bar) 11q25(132,927,027-134,944,770) × 1 (h).
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the mother, he needs supervision.
Chromosome analysis from lymphocyte cultures
revealed additional material in chromosome 11q. The
patient’s mother had a normal karyotype but the
father carries a balanced translocation t(1;11)(q32;q25)
(Figure 1c). Breakpoints were defined by FISH with
bacterial artificial chromosome probes (BACs). FISH
analyses were performed with whole chromosome paint
(WCP1-Cytocell, Cambridge, UK) and using different BAC
probes from chromosomes 1 and 11, as previously reported
(Figure 1d, e and f) [17]. Further investigations using
Genome-Wide Human SNP 6.0 array (Affymetrix Inc.,
Santa Clara, CA, USA) on the patient revealed the final
cytogenomic result as:
46,XY.ish der(11)t(1;11)(q32.3;q25)pat(wcp1+,RP11-663
C5-,RP11-262H5+,RP11-15 J5+,RP11-265 F9-). arr[hg19]
1q32.3q44(212,508,954-249,224,376) × 3,11q25 (132,927,
027-134,944,770) × 1 (Figure 1g and h).
Conclusions
This is the first report of a patient with concomitant
1q32 duplication and 11q25 deletion in the literature.
The clinical features observed in our patient are more
closely similar to 1q32 duplication than to 11q25 deletion.
Comparing our patient with the 13 patients from literature
observed by Balasubramanian et al. [14] we concluded that
he presents important clinical features observed in
the “Distal Trisomy 1q Syndrome”, such as marked
developmental delay, microsomia, prominent forehead,
downslanted palpebral fissures, long lashes, relative
macrocephaly, recurrent pulmonary infections, genitouri-
nary anomalies and CHD. However, the wide range and
variety of the clinical features observed in patients
with 1q32 duplication make the genotype-phenotype
correlation extremely difficult.
The 1q32 duplicated segment in our patient presents
467 genes, including: TGFB2 gene (transforming growth
factor, beta 2), RYR2 gene (ryanodine receptor 2), and
TBCE gene (Homo sapiens tubulin folding cofactor E).
The TGFB2 gene regulates proliferation, differentiation,
adhesion, migration, and other functions in many cell
types and disruption of the TGFB/SMAD pathway,
regulated by this gene, has been implicated in a variety of
human cancers. The knockout of this gene in results in
perinatal mortality and a wide range of developmental
malformations, including CHD. The TGFB2 gene is also
involved with Loyes-Dietz syndrome 4 (OMIM #614816)
caused by heterozygous mutation in the TGFB2 gene.
Lindsay et al. [18] identified two unrelated patients
with aortic aneurysm and de novo 1q41 microdeletions
encompassing the TGFB2, one with Marfan syndrome and
the other with Loyes-Dietz syndrome-like features. The
RYR2 gene, which maps to 1q42q43, encodes a ryanodinereceptor found in cardiac muscle. Mutations in this gene
are associated with stress-induced polymorphic ventricular
tachycardia and arrhythmogenic right ventricular dysplasia.
Priori et al. [19] identified RYR2 gene mutations in 12
patients with typical catecholaminergic polymorphic
ventricular tachycardia and speculated it as a likely
candidate for this genetically transmitted arrhythmic
disorder. This gene is not involved in conotruncal
congenital malformations as observed in our patient
and other patients with 1q32 duplication. The genes
RYR2 and VTSIP are also associated to CHD. Other
genes labeled in the 1q32.3qter duplicated segment
also play an important role in neurodevelopment such
as TBCE gene located in 1q43.2.
The 11q terminal deletion disorder (Jacobsen syndrome)
presents a recognized pattern of malformation, which
depends on the size of the 11qter deletion, usually ranging
from 7 to 20 Mb. Since the first report in 1973 by
Jacobsen et al. [16] more than 100 cases have been
reported in literature. The main clinical features include
motor developmental delay, pre and postnatal growth
retardation, trigonocephaly, thrombocyto- or pancytopenia,
cardiac defects, hypertelorism, downslanted palpebral
fissures, short nose, anteverted nares, thin upper lip,
V-shaped mouth, dental anomalies, and low-set malformed
ears [20]. Evers et al. [21] described a 2-year-old boy with a
2.2 Mb deletion of 11q25qter and a 15.7 Mb terminal
duplication of 16q22.3qter, who has no heart disease or
platelet dysfunction, which are typically found in more than
90% of patients with terminal 11q deletion. This suggests
that the deletion presented in their patient does not
encompass the critical region for the Jacobsen syndrome.
Our patient presents a smaller 2 Mb deletion than
Evers et al. [21] patient, but shares some main clinical
features of Jacobsen syndrome, such as cardiac congenital
malformation, motor developmental delay, short stature,
undescended testes, high forehead, ocular hypertelorism,
downslanted palpebral fissures, anteverted nares, thick eye-
brows and high-arched palate, but he has no hematologic
abnormalities as observed in patients with Jacobsen
syndrome. However, some of these clinical features are also
described in duplication 1q32 making it extremely difficult
to determine the accurate genotype-phenotype correlation.
The 11q deletion observed in our patient is the smallest
segment described in literature and encompasses 25
genes including the JAM3 (junctional adhesion molecule
3) gene, a candidate gene for the Jacobsen syndrome
cardiac phenotype [22] and conotruncal heart defects.
This gene may be related to the atrial septal defect
presented by our patient.
An early conclusion from the genotype–phenotype
findings was that CHD are strongly associated with an
altered dose of genes that act together. And most
important, the new cytogenomic approaches enabled
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Consent
Written informed consent was obtained from the parents
of the patient for publication of this Case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal.
Abbreviations
CHD: Congenital heart defects; JAM3: Junctional adhesion molecule 3 gene;
OFC: Occipital frontal circumference; RYR2: Ryanodine receptor 2 gene;
TBCE: Homo sapiens tubulin folding cofactor E; TGFB2: Tubulin folding cofactor
E gene; VTSIP: Ventricular tachycardia, stress-induced polymorphic gene.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MIM and LDK coordinated and participated in the design of the study. VAM,
ALP and CBM carried out the clinical assessments. SST carried out
chromosomal classic and FISH analysis and LDK carried out microarray
analysis. VAM drafted the manuscript and all authors read and approved the
final manuscript. All authors read and approved the final manuscript.
Acknowledgement
This work was supported by grants from Fundação de Amparo a Pesquisa do
Estado de São Paulo (FAPESP): Grants number 2010/05123-5 and 2009/53105-9.
Author details
1Department of Morphology and Genetics, Universidade Federal de São
Paulo, São Paulo, SP, Brazil. 2Children’s Interdisciplinary Neuropsychological
Center, AFIP, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
3Department of Pathology, Cytogenomics Lab, LIM 03, Universidade de São
Paulo, Av. Dr. Enéas de Carvalho Aguiar, 155, 2° andar, bloco 12, sala 7, São
Paulo, SP, Brazil. 4Human Reproduction and Genetics Center, Department of
Collective Health, Faculdade de Medicina do ABC, Santo André, SP, Brazil.
Received: 11 June 2014 Accepted: 4 August 2014
Published: 22 August 2014
References
1. Emberger W, Petek E, Kroisel PM, Zierler H, Wagner K: Clinical and
molecular cytogenetic characterization of two patients with partial
trisomy 1q41-qter: further delineation of partial trisomy 1q syndrome.
Am J Med Genet 2001, 104:312–318.
2. Schinzel A: Catalogue of Unbalanced Chromosome Aberrations in Humans.
Berlin: Edited by Walter de Gruyter; 2001.
3. Steffensen DM, Chu EH, Speert DP, Wall PM, Meilinger K, Kelch RP: Partial
trisomy of the long arm of human chromosome 1 as demonstrated by
in situ hybridization with 5S ribosomal RNA. Hum Genet 1977, 36:25–33.
4. Flatz S, Fonatsch C: Partial trisomy 1q due to tandem duplication. Clin Genet
1979, 15:541–542.
5. Lungarotti MS, Falorni A, Calabro A, Passalacqua F, Dallapiccola B: De novo
duplication 1q32-q42: variability of phenotypic features in partial 1q
trisomics. J Med Genet 1980, 17:398–402.
6. Rasmussen SA, Frias JL, Lafer CZ, Eunpu DL, Zackai EH: Partial duplication
1q: report of four patients and review of the literature. Am J Med Genet
1990, 36:137–143.
7. Clark BJ, Lowther GW, Lee WR: Congenital ocular defects associated with an
abnormality of the human chromosome 1: trisomy 1q32-qter. J Pediatr
Ophthalmol Strabismus 1994, 31:41–45.
8. Duba HC, Erdel M, Löffler J, Bereuther L, Fischer H, Utermann B, Utermann G:
Detection of a de novo duplication of 1q32-qter by fluorescence in situ
hybridisation in a boy with multiple malformations: further delineation of
the trisomy 1q syndrome. J Med Genet 1997, 34:309–313.
9. De Brasi D, Rossi E, Giglio S, D’Agostino A, Titomanlio L, Farina V, Andria G,
Sebastio G: Inv dup del (1)(pter > q44::q44 > q42:) with the classical
phenotype of trisomy 1q42-qter. Am J Med Genet 2001, 104:127–130.10. Nowaczyk MJ, Bayani J, Freeman V, Watts J, Squire J, Xu J: De novo
1q32q44 duplication and distal 1q trisomy syndrome. Am J Med Genet
2003, 120:229–233.
11. Polityko A, Starke H, Rumyantseva N, Claussen U, Liehr T, Raskin S: Three cases
with rare interstitial rearrangements of chromosome 1 characterized by
multicolor banding. Cytogenet Genome Res 2005, 111:171–174.
12. Coccé MC, Villa O, Obregon MG, Salido M, Barreiro C, Solé F, Gallego MS:
Duplication dup(1)(q41q44) defined by fluorescence in situ hybridization:
delineation of the ‘trisomy 1q42 > qter syndrome’. Cytogenet Genome Res
2007, 118:84–86.
13. Kulikowski LD, Bellucco FT, Nogueira SI, Christofolini DM, Smith MA, de
Mello CB, Brunoni D, Melaragno MI: Pure duplication 1q41-qter: further
delineation of trisomy 1q syndromes. Am J Med Genet 2008,
146:2663–2667.
14. Balasubramanian M, Barber JC, Collinson MN, Huang S, Maloney VK, Bunyan D,
Foulds N: Inverted duplication of 1q32.1 to 1q44 characterized by array
CGH and review of distal 1q partial trisomy. Am J Med Genet 2009,
149:793–797.
15. Utine GE, Aktas D, Alanay Y, Gücer S, Tuncbilek E, Mrasek K, Liehr T: Distal
partial trisomy 1q: report of two cases and a review of the literature.
Prenat Diagn 2007, 27:865–871.
16. Jacobsen P, Hauge M, Henningsen K, Hobolth N, Mikkelsen M, Philip J:
An (11;21) translocation in four generations with chromosome 11
abnormalities in the offspring. A clinical, cytogenetical, and gene marker
study. Hum Hered 1973, 23:568–585.
17. Kulikowski LD, Christ LA, Nogueira SI, Brunoni D, Schwartz S, Melaragno MI:
Breakpoint mapping in a case of mosaicism with partial monosomy
9p23 > pter and partial trisomy 1q41 > qter suggests neo-telomere
formation in stabilizing the deleted chromosome. Am J Med Genet 2006,
1:82–87.
18. Lindsay ME, Schepers D, Bolar NA, Doyle J, Gallo E, Fert-Bober J, Kempers MJE,
Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid BM,
Yang MH, Bongers EMHF, Timmermans J, Braverman AC, Canham N, Mortier GR,
Brunner HG, Byers PH, Van Eyk J, Van Laer L, Dietz HC, Loeys BL: Loss-of-function
mutations in TGFB2 cause a syndromic presentation of thoracic aortic
aneurysm. Nature Genet 2012, 44:922–927.
19. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V,
Danieli GA: Mutations in the cardiac ryanodine receptor gene (hRyR2)
Underlie catecholaminergic polymorphic ventricular tachycardia.
Circulation 2001, 103:196–200.
20. Grossfeld PD, Mattina T, Lai Z, Favier R, Jones KL, Cotter F, Jones C: The 11q
terminal deletion disorder: a prospective study of 110 cases. Am J Med
Genet 2004, 129:51–61.
21. Evers C, Janssen JW, Jauch A, Bonin M, Moog U: A small terminal deletion
11q in a boy without Jacobsen syndrome: narrowing the critical region
for the 11q Jacobsen syndrome phenotype. Am J Med Genet 2012,
158:680–684.
22. Phillips HM, Renforth GL, Spalluto C, Hearn T, Curtis AR, Craven L, Havarani B,
Clement-Jones M, English C, Stumper O, Salmon T, Hutchinson S, Jackson MS,
Wilson DI: Narrowing the critical region within 11q24-qter for hypoplastic
left heart and identification of a candidate gene, JAM3, expressed during
cardiogenesis. Genomics 2002, 79:475–478.
doi:10.1186/s13039-014-0057-8
Cite this article as: Meloni et al.: Trisomy 1q32 and monosomy 11q25
associated with congenital heart defect: cytogenomic delineation and
patient fourteen years follow-up. Molecular Cytogenetics 2014 7:57.
